Haploidentical hematopoietic stem cell transplantation in the treatment of hematological malignancies using CAMPATH-1H [alemtuzumab]
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2011
At a glance
- Drugs Alemtuzumab (Primary) ; Busulfan; Ciclosporin; Cyclophosphamide; Methotrexate
- Indications Haematological malignancies; Transplant rejection
- Focus Therapeutic Use
- 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials).
- 11 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2007 New trial record.